rs4803335

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_181882.3(PRX):​c.471G>A​(p.Glu157Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0111 in 1,610,576 control chromosomes in the GnomAD database, including 1,209 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 128 hom., cov: 33)
Exomes 𝑓: 0.011 ( 1081 hom. )

Consequence

PRX
NM_181882.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.13

Publications

1 publications found
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]
PRX Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease type 4F
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • Charcot-Marie-Tooth disease type 3
    Inheritance: AD, AR Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 19-40397881-C-T is Benign according to our data. Variant chr19-40397881-C-T is described in ClinVar as Benign. ClinVar VariationId is 329288.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.13 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.109 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRXNM_181882.3 linkc.471G>A p.Glu157Glu synonymous_variant Exon 7 of 7 ENST00000324001.8 NP_870998.2
PRXNM_001411127.1 linkc.756G>A p.Glu252Glu synonymous_variant Exon 7 of 7 NP_001398056.1
PRXXM_017027047.2 linkc.369G>A p.Glu123Glu synonymous_variant Exon 4 of 4 XP_016882536.1
PRXNM_020956.2 linkc.*676G>A 3_prime_UTR_variant Exon 6 of 6 NP_066007.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkc.471G>A p.Glu157Glu synonymous_variant Exon 7 of 7 1 NM_181882.3 ENSP00000326018.6

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2321
AN:
152220
Hom.:
126
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00441
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.113
Gnomad ASJ
AF:
0.000288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00766
Gnomad FIN
AF:
0.00414
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.0196
GnomAD2 exomes
AF:
0.0337
AC:
8100
AN:
240040
AF XY:
0.0264
show subpopulations
Gnomad AFR exome
AF:
0.00374
Gnomad AMR exome
AF:
0.214
Gnomad ASJ exome
AF:
0.000103
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00310
Gnomad NFE exome
AF:
0.00395
Gnomad OTH exome
AF:
0.0222
GnomAD4 exome
AF:
0.0107
AC:
15627
AN:
1458238
Hom.:
1081
Cov.:
35
AF XY:
0.00997
AC XY:
7230
AN XY:
725260
show subpopulations
African (AFR)
AF:
0.00296
AC:
99
AN:
33462
American (AMR)
AF:
0.203
AC:
8914
AN:
43888
Ashkenazi Jewish (ASJ)
AF:
0.0000385
AC:
1
AN:
26002
East Asian (EAS)
AF:
0.0000757
AC:
3
AN:
39640
South Asian (SAS)
AF:
0.00986
AC:
845
AN:
85662
European-Finnish (FIN)
AF:
0.00323
AC:
171
AN:
52940
Middle Eastern (MID)
AF:
0.00503
AC:
29
AN:
5764
European-Non Finnish (NFE)
AF:
0.00443
AC:
4922
AN:
1110698
Other (OTH)
AF:
0.0107
AC:
643
AN:
60182
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
826
1652
2477
3303
4129
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0153
AC:
2328
AN:
152338
Hom.:
128
Cov.:
33
AF XY:
0.0171
AC XY:
1275
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.00440
AC:
183
AN:
41596
American (AMR)
AF:
0.113
AC:
1732
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.000288
AC:
1
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00766
AC:
37
AN:
4828
European-Finnish (FIN)
AF:
0.00414
AC:
44
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00426
AC:
290
AN:
68026
Other (OTH)
AF:
0.0194
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
99
199
298
398
497
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
22
44
66
88
110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00739
Hom.:
19
Bravo
AF:
0.0272
Asia WGS
AF:
0.00866
AC:
30
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

Charcot-Marie-Tooth disease Benign:1
Molecular Genetics Laboratory, London Health Sciences Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Charcot-Marie-Tooth disease type 4F Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Charcot-Marie-Tooth disease type 4 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.50
CADD
Benign
12
DANN
Benign
0.58
PhyloP100
1.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4803335; hg19: chr19-40903788; API